According to reports, the Supreme Court of British Columbia in Canada has rejected Altria Group's application to stay or dismiss lawsuits against the company in collective action against Juul Labs. Altria owns 35% of Juul.
The statement alleges that Altria and Juul colluded to market nicotine e-cigarettes to young people with the aim of converting some into smokers through nicotine addiction.
A class-action lawsuit was filed in September 2019. Following this, the Canadian health department issued a recommendation for e-cigarette users to "monitor themselves for symptoms of lung disease... and seek medical attention immediately if they have concerns about their health.
Daniel Bach, a partner at Siskinds law firm, commented on the Supreme Court decision, stating, "This is an important decision that ensures Canadians can sue all parties they believe have caused them harm." He added, "We look forward to filing a lawsuit against Altria based on the particulars of this case.
In recent years, Juul has been hit by lawsuits and increasingly strict limitations on the production and sale of e-cigarette products. As a result, this e-cigarette manufacturer has suffered financial losses.
Since 2019, Juul has halted all U.S. advertising, discontinued most flavors, and attempted to reposition itself as a product aimed at older smokers seeking an alternative to smoking.
According to media reports, Juul has been preparing to file for Chapter 11 bankruptcy protection.
This is the second appeal by Altria against a dismissed class action lawsuit in British Columbia Province Court. In October 2021, the BC Court of Appeal dismissed an appeal against an order allowing cross-examination of its affidavit in a challenge of the company's jurisdiction.
Statement:
This article is compiled from third-party information and is intended for industry exchange and learning purposes only.
This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the truth or accuracy of the article's content. The translation of this article is intended only for internal industry communications and research.
Due to limitations in translation ability, the article may not accurately convey the original text. Please refer to the original text for accuracy.
2FIRSTS maintains full alignment with the Chinese government on any statements or positions related to domestic issues, issues involving Hong Kong, Macau, Taiwan, and international affairs.
The compilation of information is owned by the original media and authors. If there is any infringement, please contact us for removal.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
